HAP Trading’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-575,900
Closed -$205K 1614
2019
Q3
$205K Sell
575,900
-49,000
-8% -$4.66M 0.02% 493
2019
Q2
$502K Sell
624,900
-1,825,400
-74% -$173M 0.04% 332
2019
Q1
$836K Buy
2,450,300
+2,412,600
+6,399% +$211M 0.07% 207
2018
Q4
$561K Buy
37,700
+400
+1% +$29.5K 0.04% 343
2018
Q3
$139K Sell
37,300
-53,800
-59% -$4.75M 0.01% 499
2018
Q2
$404K Buy
91,100
+14,800
+19% +$1.23M 0.02% 357
2018
Q1
$642K Sell
76,300
-19,500
-20% -$1.87M 0.03% 290
2017
Q4
$391K Buy
+95,800
New +$10.8M 0.02% 419
2017
Q3
Sell
-10,900
Closed -$13K 1184
2017
Q2
$13K Sell
10,900
-6,100
-36% -$747K ﹤0.01% 831
2017
Q1
$48K Buy
17,000
+5,000
+42% +$598K ﹤0.01% 691
2016
Q4
$56K Sell
12,000
-6,300
-34% -$702K ﹤0.01% 637
2016
Q3
$76K Sell
18,300
-5,200
-22% -$563K ﹤0.01% 635
2016
Q2
$35K Buy
23,500
+13,400
+133% +$1.39M ﹤0.01% 661
2016
Q1
$68K Sell
10,100
-12,000
-54% -$1.24M 0.01% 495
2015
Q4
$43K Buy
22,100
+4,900
+28% +$567K ﹤0.01% 661
2015
Q3
$73K Buy
17,200
+5,300
+45% +$658K ﹤0.01% 660
2015
Q2
$7K Sell
11,900
-6,400
-35% -$732K ﹤0.01% 883
2015
Q1
$57K Buy
18,300
+2,000
+12% +$239K ﹤0.01% 607
2014
Q4
$45K Buy
+16,300
New +$1.72M ﹤0.01% 748

Other funds holding CELG

HAP Trading's CELG Position: Q1 2019 in Review

HAP Trading sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 15,393 shares — an estimated $1.35M sold.

HAP Trading first reported a position in CELG in Q4 2017 and held it in 3 quarters. The position peaked at $3.81M in Q1 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • HAP Trading reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • HAP Trading sold 15,393 Celgene Corp shares in Q1 2019, an estimated $1.35M.
  • HAP Trading first reported a position in Celgene Corp in Q4 2017 and held it in 3 quarters.
  • HAP Trading's Celgene Corp position peaked at $3.81M in Q1 2018.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on HAP Trading's 13F filing for Q1 2019, filed 10 May 2019.